PMID: 2118954Jul 1, 1990Paper

Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin

Journal of Pharmaceutical Sciences
V SrinivasanC R Behl

Abstract

This paper explores the possibility of iontophoretically enhancing the in vitro transdermal flux of two polypeptides: leuprolide (a LHRH analogue; MW = 1209.4) and a cholecystokinin-8 analogue (CCK-8; MW = 1150.17). Control experiments at an applied voltage of 0.5 V across full-thickness human skin did not yield measurable fluxes of either polypeptide, suggesting that despite the expected iontophoretic flux enhancements, the intrinsic permeability of these polypeptides through skin may be too low to allow significant amounts of the drug to permeate. Therefore, pretreatment with ethanol (to simulate the effect of a chemical permeation enhancer) followed by iontophoresis was investigated with the aim of evaluating the potential of the enhancer plus ionophoresis as a means for controlled transdermal delivery of these polypeptides. The ethanol pretreatment dramatically increased the passive fluxes of both polypeptides, and iontophoresis produced further enhancements in their fluxes. Also, the experimental enhancement factors for leuprolide as a function of the applied voltage appeared to be generally lower than the predictions of the constant field theory. A synergism of iontophoresis with a chemical permeation enhancer may be a po...Continue Reading

Citations

Sep 1, 1993·Medicinal Research Reviews·S Singh, J Singh
Dec 31, 2003·International Journal of Pharmaceutics·Omathanu PillaiRamesh Panchagnula
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·L LangkjaerR H Guy
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Y OhJ H Lee
Mar 16, 2001·International Journal of Pharmaceutics·S K Rastogi, J Singh
Aug 8, 2001·International Journal of Pharmaceutics·S K Rastogi, J Singh
Mar 4, 1999·International Journal of Pharmaceutics·Y QiuM Y Lu
Mar 8, 2000·International Journal of Pharmaceutics·N KanikkannanP Ramarao
Mar 23, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M KirjavainenJ Hirvonen
Sep 1, 1994·The Journal of Pharmacy and Pharmacology·S ThysmanV Préat
Jan 18, 2008·Journal of Pharmaceutical Sciences·Heather A E Benson, Sarika Namjoshi
Sep 7, 2004·Journal of Pharmaceutical Sciences·Mariella ArtusiPatrizia Santi
May 19, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·D D Verma, A Fahr
Sep 22, 2009·Trends in Biotechnology·Zuzana AntosovaTomas Macek
Feb 24, 2005·International Journal of Pharmaceutics·P SebastianiP Santi
Oct 22, 2002·Expert Opinion on Biological Therapy·Elka Touitou
Dec 8, 2000·Pharmaceutical Development and Technology·Y WangL C Li
Mar 26, 2004·Nature Reviews. Drug Discovery·Mark R PrausnitzRobert Langer
Nov 10, 2021·Biomaterials Science·Shuyao RuanNianping Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.